Skip to main content

Becton Dickinson & Co

BDX
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000010795

In the last 90 days, Becton Dickinson & Co insiders filed 0 open-market purchases and 4 sales; 1,446 institutions reported holding it in 13F filings for Q2 2026, worth $41.2B in total; superinvestors Greenhaven Associates and Harris Associates (Oakmark) hold it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.25M in total
4
13F holdersQ2 2026, −10 vs. previous quarter
1,446
13F valueReported value at the end of Q2 2026
$41.2B
Superinvestors holdingAt the end of Q2 2026
2

Price chart

Superinvestors holding BDX, Q2 2026

2 superinvestors report holding Becton Dickinson & Co on Form 13F. Percentages are the stock's share of each portfolio.

Go to the superinvestors tab

Greenhaven Associates

Edgar Wachenheim III

9.9%

Becton Dickinson & Co's share of the portfolio

Shares
5,681,708
Value
$859.8M

Harris Associates (Oakmark)

Bill Nygren

0.5%

Becton Dickinson & Co's share of the portfolio

Shares
2,350,963
Value
$355.8M

Latest insider trades

Open-market purchases and sales by Becton Dickinson & Co insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 27, 2026 (view filing)4:28 PM ETAug 261 dayFeld MichaelEVP, Chief Revenue OfficerSSale−165$188.49−$31.1K−0.8%19.7K after10b5-1
Aug 14, 2026 (view filing)4:36 PM ETAug 131 dayPolen Thomas E JrChairman, CEO and PresidentSSale−4.15K$185.00−$768.1K−3.6%110.2K after10b5-1
Aug 12, 2026 (view filing)5:27 PM ETAug 111 dayGoette RolandEVP and President, EMEASSale−2.44K$180.84−$440.9K−14.1%14.9K after
Jul 28, 2026 (view filing)11:16 AM ETJul 271 dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$157.13−$11.8K−0.4%20.9K after10b5-1
Jun 26, 2026 (view filing)Jun 26Same dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$152.80−$11.5K−0.4%21.0K after10b5-1
Jun 25, 2026 (view filing)Jun 241 dayGarrison Michael DavidEVP & Pres Med.Essntl&BioPharmSSale−1.10K$145.66−$160.2K−7.7%13.2K after10b5-1
Jun 11, 2026 (view filing)Jun 101 dayGarrison Michael DavidEVP & Pres Med.Essntl&BioPharmSSale−1.10K$151.48−$166.6K−7.2%14.3K after10b5-1
Jun 3, 2026 (view filing)Jun 12 daysPolen Thomas E JrChairman, CEO and PresidentSSale−2.76K$146.35−$404.5K−2.4%110.2K after10b5-1
May 27, 2026 (view filing)May 261 dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$147.35−$11.1K−0.4%21.1K after10b5-1
Apr 28, 2026 (view filing)Apr 271 dayFeld MichaelEVP, Chief Revenue OfficerSSale−74$151.94−$11.2K−0.3%21.2K after10b5-1

Top 10 13F holders, Q2 2026

The largest institutional positions in Becton Dickinson & Co at the end of Q2 2026; share changes are against Q1 2026.

See all 1,446 holders
Institutions holding BDX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.24,592,166$3.72B0.06%−1,561,245−6.0%Reduced
Vanguard Capital Management LLC17,987,834$2.72B0.06%−502,776−2.7%Reduced
Massachusetts Financial Services Co8,650,967$2.48B0.79%−450,487−4.9%Reduced
State Street Corp15,000,064$2.27B0.07%+1,177,256+8.5%Added
Vanguard Portfolio Management LLC14,974,136$2.27B0.10%−343,106−2.2%Reduced
First Eagle Investment Management, LLC13,815,335$2.09B3.44%+1,887,224+15.8%Added
Invesco Ltd.8,898,488$1.35B0.11%−1,275,839−12.5%Reduced
Geode Capital Management, LLC8,141,586$1.23B0.07%+1,034,323+14.6%Added
Franklin Resources Inc7,011,592$1.06B0.23%+1,648,627+30.7%Added
Wellington Management Group LLP6,357,986$962.2M0.17%−257,244−3.9%Reduced